A detailed history of Capital Insight Partners, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Capital Insight Partners, LLC holds 60,328 shares of EW stock, worth $4.21 Million. This represents 0.71% of its overall portfolio holdings.

Number of Shares
60,328
Previous 56,038 7.66%
Holding current value
$4.21 Million
Previous $5.18 Million 23.09%
% of portfolio
0.71%
Previous 0.99%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

BUY
$59.7 - $93.78 $256,113 - $402,316
4,290 Added 7.66%
60,328 $3.98 Million
Q2 2024

Jul 24, 2024

SELL
$84.3 - $94.31 $38,693 - $43,288
-459 Reduced 0.81%
56,038 $5.18 Million
Q1 2024

Apr 16, 2024

BUY
$72.54 - $95.56 $478,909 - $630,887
6,602 Added 13.23%
56,497 $5.4 Million
Q4 2023

Jan 24, 2024

BUY
$61.71 - $77.76 $98,057 - $123,560
1,589 Added 3.29%
49,895 $3.8 Million
Q3 2023

Oct 30, 2023

BUY
$69.28 - $93.38 $176,386 - $237,745
2,546 Added 5.56%
48,306 $3.35 Million
Q2 2023

Jul 21, 2023

SELL
$81.41 - $94.33 $13,269 - $15,375
-163 Reduced 0.35%
45,760 $4.32 Million
Q1 2023

Apr 27, 2023

BUY
$74.26 - $84.51 $66,165 - $75,298
891 Added 1.98%
45,923 $3.8 Million
Q4 2022

Feb 07, 2023

BUY
$68.3 - $87.44 $86,536 - $110,786
1,267 Added 2.9%
45,032 $3.36 Million
Q3 2022

Oct 20, 2022

BUY
$82.37 - $107.29 $49,998 - $65,125
607 Added 1.41%
43,765 $3.62 Million
Q2 2022

Jul 20, 2022

BUY
$86.5 - $128.27 $27,161 - $40,276
314 Added 0.73%
43,158 $4.1 Million
Q1 2022

Apr 21, 2022

BUY
$101.96 - $128.34 $262,241 - $330,090
2,572 Added 6.39%
42,844 $5.04 Million
Q4 2021

Jan 20, 2022

BUY
$106.37 - $130.68 $89,989 - $110,555
846 Added 2.15%
40,272 $5.22 Million
Q3 2021

Oct 13, 2021

SELL
$102.91 - $122.75 $1,646 - $1,964
-16 Reduced 0.04%
39,426 $4.46 Million
Q2 2021

Aug 02, 2021

BUY
$83.84 - $104.76 $84,426 - $105,493
1,007 Added 2.62%
39,442 $4.09 Million
Q1 2021

Apr 20, 2021

BUY
$78.68 - $90.67 $142,646 - $164,384
1,813 Added 4.95%
38,435 $3.22 Million
Q4 2020

Feb 02, 2021

BUY
$71.69 - $91.23 $42,153 - $53,643
588 Added 1.63%
36,622 $3.34 Million
Q3 2020

Nov 04, 2020

BUY
$67.19 - $87.44 $2,217 - $2,885
33 Added 0.09%
36,034 $2.88 Million
Q2 2020

Jul 15, 2020

BUY
$57.54 - $76.95 $1.39 Million - $1.86 Million
24,224 Added 205.69%
36,001 $2.49 Million
Q1 2020

Apr 14, 2020

BUY
$52.41 - $81.0 $59,223 - $91,530
1,130 Added 10.61%
11,777 $2.22 Million
Q4 2019

Jan 27, 2020

SELL
$71.7 - $82.09 $774,575 - $886,818
-10,803 Closed
0 $0
Q3 2019

Oct 09, 2019

SELL
$61.55 - $75.43 $15,387 - $18,857
-250 Reduced 2.26%
10,803 $2.38 Million
Q2 2019

Jul 09, 2019

BUY
$55.74 - $64.41 $2,396 - $2,769
43 Added 0.39%
11,053 $2.04 Million
Q1 2019

Apr 04, 2019

BUY
$47.89 - $64.05 $2,538 - $3,394
53 Added 0.48%
11,010 $2.11 Million
Q4 2018

Jan 03, 2019

BUY
$46.41 - $56.94 $2,227 - $2,733
48 Added 0.44%
10,957 $1.68 Million
Q3 2018

Oct 04, 2018

BUY
$45.7 - $58.03 $498,541 - $633,049
10,909 New
10,909 $1.9 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $43.1B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Capital Insight Partners, LLC Portfolio

Follow Capital Insight Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Insight Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Insight Partners, LLC with notifications on news.